TNF and rheumatoid arthritis: Biologic DMARDs (bDMARDs) such as tumor necrosis factor inhibitor (TNFi), tocilizumab (TCZ) and abatacept have provided dramatic changes in the management of RA, making remission an achievable goal in many patients [2].